Dow Corning breast implant report
This article was originally published in The Gray Sheet
Judge Samuel Pointer of the U.S. District Court in Birmingham, Alabama rules that the report prepared by former Attorney General Griffen Bell on the company's breast implant business is confidential under the attorney/client relationship and does not have to be released to the public or FDA, according to Dow. The agency had asked the company to release the report ("The Gray Sheet" Jan. 18, I&W-4). Judge Pointer, who has multi-district responsibility for silicone breast implant lawsuits, rendered the decision at a recent pre-trial conference in Washington, D.C. The next conferences are scheduled for Feb. 24 in San Francisco and March 25 in Birmingham, Alabama.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.